Lund University
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
The researchers used mass spec and data analytics to develop lipid profiles that predicted diabetes and cardiovascular disease risk in the distant future.
The approval of Biogen's Alzheimer's disease treatment in June was seen as an important regulatory development for companies developing tests.
Over the next three years, Immunovia and its partners will use the firm's Immray PanCan-d assay to screen 6,000 diabetes patients for pancreatic cancer.
Since it launched CADscor, which could compete against molecular tests, in the second quarter, Acarix has announced clients in Germany, Denmark, and Sweden.